<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">

<pmc-articleset><article article-type="research-article" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink">
<?properties open_access?>
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">Mol Genet Genomic Med</journal-id>
<journal-id journal-id-type="iso-abbrev">Mol Genet Genomic Med</journal-id>
<journal-id journal-id-type="doi">10.1002/(ISSN)2324-9269</journal-id>
<journal-id journal-id-type="publisher-id">MGG3</journal-id>
<journal-title-group>
<journal-title>Molecular Genetics &amp; Genomic Medicine</journal-title>
</journal-title-group>
<issn pub-type="epub">2324-9269</issn>
<publisher>
<publisher-name>John Wiley and Sons Inc.</publisher-name>
<publisher-loc>Hoboken</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="pmid">31578829</article-id>
<article-id pub-id-type="pmc">6978259</article-id>
<article-id pub-id-type="doi">10.1002/mgg3.992</article-id>
<article-id pub-id-type="publisher-id">MGG3992</article-id>
<article-categories>
<subj-group subj-group-type="overline">
<subject>Clinical Report</subject>
</subj-group>
<subj-group subj-group-type="heading">
<subject>Clinical Report</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Exome sequencing study of partial agenesis of the corpus callosum in men with developmental delay, epilepsy, and microcephaly</article-title>
<alt-title alt-title-type="left-running-head">MELOCHE et al.</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" id="mgg3992-cr-0001">
<name>
<surname>Meloche</surname>
<given-names>Jolyane</given-names>
</name>
<contrib-id authenticated="false" contrib-id-type="orcid">https://orcid.org/0000-0001-5234-2326</contrib-id>
<xref ref-type="aff" rid="mgg3992-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="mgg3992-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3992-cr-0002">
<name>
<surname>Brunet</surname>
<given-names>Vanessa</given-names>
</name>
<xref ref-type="aff" rid="mgg3992-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3992-cr-0003">
<name>
<surname>Gagnon</surname>
<given-names>Pierre‐Alexandre</given-names>
</name>
<xref ref-type="aff" rid="mgg3992-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="mgg3992-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3992-cr-0004">
<name>
<surname>Lavoie</surname>
<given-names>Marie‐Ève</given-names>
</name>
<xref ref-type="aff" rid="mgg3992-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="mgg3992-aff-0002">
<sup>2</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3992-cr-0005">
<name>
<surname>Bouchard</surname>
<given-names>Jean‐Benoît</given-names>
</name>
<xref ref-type="aff" rid="mgg3992-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3992-cr-0006">
<name>
<surname>Nadaf</surname>
<given-names>Javad</given-names>
</name>
<xref ref-type="aff" rid="mgg3992-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3992-cr-0007">
<name>
<surname>Majewski</surname>
<given-names>Jacek</given-names>
</name>
<xref ref-type="aff" rid="mgg3992-aff-0004">
<sup>4</sup>
</xref>
</contrib>
<contrib contrib-type="author" id="mgg3992-cr-0008">
<name>
<surname>Morin</surname>
<given-names>Charles</given-names>
</name>
<xref ref-type="aff" rid="mgg3992-aff-0003">
<sup>3</sup>
</xref>
</contrib>
<contrib contrib-type="author" corresp="yes" id="mgg3992-cr-0009">
<name>
<surname>Laprise</surname>
<given-names>Catherine</given-names>
</name>
<xref ref-type="aff" rid="mgg3992-aff-0001">
<sup>1</sup>
</xref>
<xref ref-type="aff" rid="mgg3992-aff-0002">
<sup>2</sup>
</xref>
<address>
<email>catherine.laprise@uqac.ca</email>
</address>
</contrib>
</contrib-group>
<aff id="mgg3992-aff-0001">
<label><sup>1</sup></label>
<named-content content-type="organisation-division">Centre intersectoriel en santé durable</named-content>
<institution>Université du Québec à Chicoutimi</institution>
<city>Saguenay</city>
<named-content content-type="country-part">QC</named-content>
<country country="CA">Canada</country>
</aff>
<aff id="mgg3992-aff-0002">
<label><sup>2</sup></label>
<named-content content-type="organisation-division">Département des Sciences Fondamentales</named-content>
<institution>Université du Québec à Chicoutimi</institution>
<city>Saguenay</city>
<named-content content-type="country-part">QC</named-content>
<country country="CA">Canada</country>
</aff>
<aff id="mgg3992-aff-0003">
<label><sup>3</sup></label>
<institution>Centre de Santé et de Services Sociaux de Chicoutimi</institution>
<city>Saguenay</city>
<named-content content-type="country-part">QC</named-content>
<country country="CA">Canada</country>
</aff>
<aff id="mgg3992-aff-0004">
<label><sup>4</sup></label>
<named-content content-type="organisation-division">Department of Human Genetics</named-content>
<institution>McGill University and Genome Quebec Innovation Centre</institution>
<city>Montreal</city>
<named-content content-type="country-part">QC</named-content>
<country country="CA">Canada</country>
</aff>
<author-notes>
<corresp id="correspondenceTo"><label>*</label><bold>Correspondence</bold><break></break>
Catherine Laprise, Centre intersectoriel en santé durable, Département des sciences fondamentales, Université du Québec à Chicoutimi, Saguenay, Québec G7H 2B1, Canada.<break></break>
Email: <email>catherine.laprise@uqac.ca</email><break></break></corresp>
</author-notes>
<pub-date pub-type="epub">
<day>02</day>
<month>10</month>
<year>2019</year>
</pub-date>
<pub-date pub-type="collection">
<month>1</month>
<year>2020</year>
</pub-date>
<volume>8</volume>
<issue>1</issue>
<issue-id pub-id-type="doi">10.1002/mgg3.v8.1</issue-id>
<elocation-id>e992</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>8</month>
<year>2018</year>
</date>
<date date-type="rev-recd">
<day>28</day>
<month>8</month>
<year>2019</year>
</date>
<date date-type="accepted">
<day>03</day>
<month>9</month>
<year>2019</year>
</date>
</history>
<permissions>
<!--<copyright-statement content-type="issue-copyright"> Copyright &#x000a9; 2020 John Wiley & Sons Ltd. <copyright-statement>-->
<copyright-statement content-type="article-copyright">© 2019 The Authors. <italic>Molecular Genetics &amp; Genomic Medicine</italic> published by Wiley Periodicals, Inc.</copyright-statement>
<license license-type="creativeCommonsBy">
<license-p>This is an open access article under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">http://creativecommons.org/licenses/by/4.0/</ext-link> License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="file:MGG3-8-e992.pdf"></self-uri>
<abstract id="mgg3992-abs-0001">
<title>Abstract</title>
<sec id="mgg3992-sec-0001">
<title>Background</title>
<p>This study reports the genetic features of four Caucasian males from the Saguenay‒Lac‐St‐Jean region affected by partial agenesis of the corpus callosum (ACC) with hypotonia, epilepsy, developmental delay, microcephaly, hypoplasia, and autistic behavior.</p>
</sec>
<sec id="mgg3992-sec-0002">
<title>Methods</title>
<p>We performed whole exome sequencing (WES) to identify new genes involved in this pathological phenotype. The regions of interest were subsequently sequenced for family members.</p>
</sec>
<sec id="mgg3992-sec-0003">
<title>Results</title>
<p>Single‐nucleotide variations (SNVs) and insertions or deletions were detected in genes potentially implicated in brain defects observed in these patients. One patient did not have mutations in genes related to ACC, but carried a de novo pathogenic mutation in Mucolipin‐1 (<italic>MCOLN1</italic>) and was diagnosed with mucolipidosis type IV. Among the other probands, missense SNVs were observed in <italic>DCLK2</italic> (Doublecortin Like Kinase 2), <italic>HERC2</italic> (HECT And RLD Domain Containing E3 Ubiquitin Protein Ligase 2), and <italic>KCNH3</italic> (Potassium channel, voltage‐gated, subfamily H, member 3). One patient also carried a non‐frameshift insertion in <italic>CACNA1A</italic> (Cav2.1(P/Q‐type) calcium channels).</p>
</sec>
<sec id="mgg3992-sec-0004">
<title>Conclusion</title>
<p>Although no common genetic defect was observed in this study, we provide evidence for new avenues of investigation for ACC, such as molecular pathways involving <italic>HERC2</italic>, <italic>CACNA1A</italic>, <italic>KCNH3,</italic> and more importantly <italic>DCLK2</italic>. We also allowed to diagnose an individual with mucolipidosis type IV.</p>
</sec>
</abstract>
<abstract abstract-type="graphical" id="mgg3992-abs-0002">
<p>We performed whole exome sequencing to identify new genes involved in partial agenesis of the corpus callosum with hypotonia, epilepsy, developmental delay, microcephaly, hypoplasia, and autistic behavior. Although no common genetic defect was observed, we provided new insights on genes potentially implicated in this pathological phenotype, such as <italic>DCLK2</italic>.<boxed-text content-type="graphic" id="mgg3992-blkfxd-0001" orientation="portrait" position="anchor"><graphic id="nlm-graphic-1" orientation="portrait" position="anchor" xlink:href="MGG3-8-e992-g002.jpg"></graphic></boxed-text>
</p>
</abstract>
<kwd-group kwd-group-type="author-generated">
<kwd id="mgg3992-kwd-0001">agenesis of the corpus callosum</kwd>
<kwd id="mgg3992-kwd-0002">
<italic>DCLK2</italic>
</kwd>
<kwd id="mgg3992-kwd-0003">exome sequencing</kwd>
<kwd id="mgg3992-kwd-0004">genetics</kwd>
</kwd-group>
<funding-group>
<award-group id="funding-0001">
<funding-source>Fondation Louis‐Philippe Gagnon</funding-source>
</award-group>
</funding-group>
<counts>
<fig-count count="1"></fig-count>
<table-count count="2"></table-count>
<page-count count="8"></page-count>
<word-count count="4665"></word-count>
</counts>
<custom-meta-group>
<custom-meta>
<meta-name>source-schema-version-number</meta-name>
<meta-value>2.0</meta-value>
</custom-meta>
<custom-meta>
<meta-name>cover-date</meta-name>
<meta-value>January 2020</meta-value>
</custom-meta>
<custom-meta>
<meta-name>details-of-publishers-convertor</meta-name>
<meta-value>Converter:WILEY_ML3GV2_TO_JATSPMC version:5.7.5 mode:remove_FC converted:23.01.2020</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
<notes>
<p content-type="self-citation">
<mixed-citation id="mgg3992-cit-1001" publication-type="journal">
<string-name>
<surname>Meloche</surname>
<given-names>J</given-names>
</string-name>, <string-name>
<surname>Brunet</surname>
<given-names>V</given-names>
</string-name>, <string-name>
<surname>Gagnon</surname>
<given-names>P‐A</given-names>
</string-name>, et al. <article-title>Exome sequencing study of partial agenesis of the corpus callosum in men with developmental delay, epilepsy, and microcephaly</article-title>. <source xml:lang="en"/>Mol Genet Genomic Med. <year>2020</year>;<volume>8</volume>:<elocation-id>e992</elocation-id>
<pub-id pub-id-type="doi">10.1002/mgg3.992</pub-id>
</mixed-citation>
</p>
</notes>
</front>
<body id="mgg3992-body-0001">
<sec id="mgg3992-sec-0005">
<label>1</label>
<title>INTRODUCTION</title>
<p>The corpus callosum is the largest white matter tract in the human brain (Mihrshahi, <xref ref-type="ref" rid="mgg3992-bib-0015">2006</xref>). It is essential for communication as it coordinates and transfers information between the two cerebral hemispheres (Aboitiz &amp; Montiel, <xref ref-type="ref" rid="mgg3992-bib-0002">2003</xref>). It plays a critical role in cognition, as well as in various sensory and motor functions (Mihrshahi, <xref ref-type="ref" rid="mgg3992-bib-0015">2006</xref>). As early as 6 weeks of gestation, the 200 million axons that will become the corpus callosum are growing within the hemispheres. These fibers will start closing the gap between the 11th and 12th week of gestation. The partial or complete absence of this commissure is called a partial or complete agenesis of the corpus callosum (ACC). ACC is among the most frequent human brain malformations, occurring in 1:4000 individuals (Paul et al., <xref ref-type="ref" rid="mgg3992-bib-0018">2007</xref>). Although the exact mechanisms implicated in ACC etiology are unknown, current evidence suggests that genetic alterations, such as single gene mutation or more complex genetic abnormalities, are implicated in its development.</p>
<p>The Saguenay–Lac‐St‐Jean (SLSJ) region is in the northeastern Quebec in Canada. Most of the SLSJ population is of French‐Canadian descent and this region was marked by three successive founder effects, which contributed to shape its unique genetic pool (De Braekeleer, Dallaire, &amp; Mathieu, <xref ref-type="ref" rid="mgg3992-bib-0007">1993</xref>). Because of this, several genetic disorders have been described in this population, such as the hereditary motor and sensory neuropathy associated with ACC, known as the Andermann syndrome.(OMIM #218000) This syndrome was described in 1972 in patients originating from the SLSJ and Charlevoix regions (Dupre et al., <xref ref-type="ref" rid="mgg3992-bib-0009">2003</xref>; Larbrisseau, Vanasse, Brochu, &amp; Jasmin, <xref ref-type="ref" rid="mgg3992-bib-0012">1984</xref>). This disorder was classified as an autosomal recessive syndrome affecting the chromosomal region 15q13‐15 (<italic>SLC12A6</italic>, OMIM #604878) and characterized by ACC associated with a progressive motor neuropathy.</p>
<p>More recently, physicians noticed that some children affected by partial ACC in the SLSJ region had a specific phenotype. Their ACC was not associated with Andermann syndrome or other syndromes commonly associated with ACC (Bedeschi et al., <xref ref-type="ref" rid="mgg3992-bib-0004">2006</xref>; Taylor &amp; David, <xref ref-type="ref" rid="mgg3992-bib-0023">1998</xref>; van Bon et al., <xref ref-type="ref" rid="mgg3992-bib-0025">2008</xref>; Volpe et al., <xref ref-type="ref" rid="mgg3992-bib-0026">2006</xref>). In contrast, they had a specific phenotype: partial ACC associated with microcephaly, hypoplasia, developmental delay, epilepsy, and autistic behavior. In this context, we hypothesized that there might be a common genetic disorder causing this pathological phenotype involving epilepsy, developmental delay, microcephaly, hypoplasia, as well as partial ACC. Consequently, the objective of this study was to define common genes and/or variations implicated in this pathological phenotype using whole exome sequencing (WES) on several individuals presenting these clinical symptoms. As shown by Topper et al., WES is a promising technique for identifying new genes involved in intellectual disability (Topper, Ober, &amp; Das, <xref ref-type="ref" rid="mgg3992-bib-0024">2011</xref>).</p>
</sec>
<sec id="mgg3992-sec-0006" sec-type="materials-and-methods">
<label>2</label>
<title>MATERIALS AND METHODS</title>
<sec id="mgg3992-sec-0007">
<label>2.1</label>
<title>Editorial policies and ethical considerations</title>
<p>Ethical approval was obtained from the appropriate institutional ethic committees (<italic>Centre intégré universitaire de santé et de services sociaux</italic> (CIUSSS) du SLSJ and <italic>Université du Québec à Chicoutimi</italic> (UQAC)) and all individuals gave written informed consent.</p>
</sec>
<sec id="mgg3992-sec-0008">
<label>2.2</label>
<title>Sample selection</title>
<p>Following the genetic structure of the population of SLSJ, known for its founder effect (Scriver, <xref ref-type="ref" rid="mgg3992-bib-0021">2001</xref>), we included patients with partial ACC associated with epilepsy (refractory seizures; mixed generalized or partial focal to bilateral tonic‐clonic seizures), delayed psychomotor development, microcephaly (head circumference at birth &lt;3rd percentile), midfacial hypoplasia, low hair implantation, autism or autistic behavior, and with at least one grandparent native of SLSJ. These patients presented isolated partial ACC, as they did not have any other central nervous system disorders. At the neuropsychological level, all probands exhibited a profound intellectual retardation. These clinical characteristics will be considered as the “pathological phenotype.” The exclusion criteria were the presence of polyneuropathy and/or a chromosomal abnormality already documented. Medical files of all minors with these specific symptoms and their relatives were obtained from the participating medical center archives and were reviewed. A total of four patients with similar clinical characteristics were included in this study (Table <xref ref-type="table" rid="mgg3992-tbl-0001">1</xref>). We also included parents of the patients with ACC, as well as their sibling (brothers in these cases), when possible, to compare genotypes. All probands were Caucasian males.</p>
<table-wrap id="mgg3992-tbl-0001" orientation="portrait" position="float" xml:lang="en">
<label>Table 1</label>
<caption>
<p>Clinical and phenotypic data of the probands</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Patient</th>
<th align="left" colspan="1" rowspan="1" valign="top">Age</th>
<th align="left" colspan="1" rowspan="1" valign="top">
<p>Clinical features shared by all probands</p>
<p>(inclusion criteria)</p>
</th>
<th align="left" colspan="1" rowspan="1" valign="top">Other diseases and medical condition</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="1">1</td>
<td align="left" colspan="1" rowspan="1">23</td>
<td align="left" colspan="1" rowspan="4">
<list id="mgg3992-list-0001" list-type="bullet"><list-item><p>Partial agenesis of the corpus callosum</p></list-item><list-item><p>Hypotonia</p></list-item><list-item><p>Epilepsy</p></list-item><list-item><p>Autistic behavior</p></list-item><list-item><p>Delayed psychomotor development</p></list-item><list-item><p>Midfacial hypoplasia</p></list-item><list-item><p>Microcephaly</p></list-item><list-item><p>Absence of polyneuropathy</p></list-item><list-item><p>Absence of known chromosomal abnormalities</p></list-item></list>
</td>
<td align="left" colspan="1" rowspan="1">
<list id="mgg3992-list-0002" list-type="bullet"><list-item><p>Attention deficit hyperactivity disorder</p></list-item><list-item><p>Alternate esotropia (strabismus)</p></list-item><list-item><p>Behavioral disorder</p></list-item><list-item><p>Eczema</p></list-item><list-item><p>Negative Angelman test</p></list-item><list-item><p>Pityriasis rosea</p></list-item><list-item><p>Gastritis</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">2</td>
<td align="left" colspan="1" rowspan="1">21</td>
<td align="left" colspan="1" rowspan="1">
<list id="mgg3992-list-0003" list-type="bullet"><list-item><p>Hyperactivity</p></list-item><list-item><p>Growth retardation at birth</p></list-item><list-item><p>Delayed language</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">3</td>
<td align="left" colspan="1" rowspan="1">40</td>
<td align="left" colspan="1" rowspan="1">
<list id="mgg3992-list-0004" list-type="bullet"><list-item><p>Anemia</p></list-item><list-item><p>Major handicap (no words)</p></list-item><list-item><p>Hypomagnesaemia</p></list-item><list-item><p>Folic acid deficit</p></list-item><list-item><p>Cerebral palsy</p></list-item><list-item><p>Spastic quadriplegia</p></list-item><list-item><p>Bowel obstruction</p></list-item><list-item><p>Volvulus</p></list-item><list-item><p>Scoliosis</p></list-item></list>
</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="left" colspan="1" rowspan="1">18</td>
<td align="left" colspan="1" rowspan="1">
<list id="mgg3992-list-0005" list-type="bullet"><list-item><p>Thoracic convexity to the right</p></list-item><list-item><p>Fulminant hepatitis</p></list-item><list-item><p>Asthma and food allergies</p></list-item><list-item><p>Growth retardation at birth</p></list-item></list>
</td>
</tr>
</tbody>
</table>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
</sec>
<sec id="mgg3992-sec-0009">
<label>2.3</label>
<title>Exome sequencing</title>
<p>DNA was extracted from blood samples of four probands and their relatives (parents, as well as brother when available) using the Blood &amp; Cell Culture DNA Mini Kit (QIAGEN) according to the manufacturer's instructions. WES was performed on the four affected individuals at the McGill University and Genome Québec Innovation Center. Exome capture was performed with the SureSelect® High Throughput Library from Agilent (Agilent Technologies). Exon‐enriched DNA was then sequenced with the HiSeq2000 Illumina technology. Libraries were sequenced in paired‐end formats for read lengths of 100 base pairs. The sequencing reads were aligned to the NCBI human reference genome (NCBI, build GRCh37/hg19) using Burrows‐Wheeler Alignment tool (BWA) (Li &amp; Durbin, <xref ref-type="ref" rid="mgg3992-bib-0014">2009</xref>). Single‐nucleotide variations (SNVs) and small insertions and deletions (INDELs) were subsequently identified using VarScan. ANNOVAR (open bioinformatics) was used to classify and annotate variants (INDELs, SNVs). SIFT (Sorting Intolerant From Tolerant) and PolyPhen‐2 (Polymorphism Phenotyping v2) were used to assess the potential pathogenicity of nonsynonymous variants (Adzhubei et al., <xref ref-type="ref" rid="mgg3992-bib-0003">2010</xref>; Ng &amp; Henikoff, <xref ref-type="ref" rid="mgg3992-bib-0017">2001</xref>). ExAC Browser was used to investigate the probability of loss of function intolerance for the candidate genes (Lek et al., <xref ref-type="ref" rid="mgg3992-bib-0013">2016</xref>).</p>
</sec>
<sec id="mgg3992-sec-0010">
<label>2.4</label>
<title>Bioinformatic filtering</title>
<p>Stringent thresholds were used for variant calling. Variants in sites covered at less than 10×, variants in sites covered in only one direction, as well as variants found in &lt;4 reads or &lt;5% of reads were excluded. Further variant filtering was performed: nongenic, intronic, and synonymous variants were excluded from our analyses. SNVs found in &gt;1% controls when compared to the 1000 Genome Project, dbSNP, and the <italic>Réseau de Médecine Génétique Appliquée</italic> (Genome Quebec, Genome Canada) databases were excluded from this study. Among these, variants including splice variants, deletions, and truncating SNVs, that were predicted pathogenic (SIFT, PolyPhen‐2), were kept for analyses. Furthermore, to find a potential gene responsible for the pathogenic characteristics of these probands with ACC, we focused our research on genes involved in the development and/or the integrity of motoneurons based on a thorough search of the literature. Genes that were biologically relevant to the pathological phenotype were selected for the next steps.</p>
</sec>
<sec id="mgg3992-sec-0011">
<label>2.5</label>
<title>Sanger sequencing</title>
<p>After narrowing our search to variants in genes known to play a role in the development or integrity of motoneurons, DNA sequencing for the region of interest in these genes was performed by Sanger sequencing at the <italic>Plateforme de Séquençage et de Génotypage des Génomes</italic> (<italic>Centre Hospitalier Universitaire de Québec‐Université Laval, Québec,</italic> Canada). This step was performed on DNA of the affected individual, as well as his parents and siblings (when possible) to confirm variants, and to identify their transmission patterns, or if they are de novo mutations.</p>
</sec>
</sec>
<sec id="mgg3992-sec-0012" sec-type="results">
<label>3</label>
<title>RESULTS</title>
<p>To find impactful genes responsible for the pathogenic characteristics of these probands with partial ACC, WES analyses were performed and variations in genes involved in the development and/or the integrity of motoneurons were prioritized. With this stringent filtering process, no variation was common to all probands. Nevertheless, variations in four genes with potential biological implication on the development and/or integrity of motoneurons were identified in three of the four affected men (Table <xref ref-type="table" rid="mgg3992-tbl-0002">2</xref>). Indeed, variations in <italic>DCLK2</italic> (Doublecortin Like Kinase 2, OMIM #613166), <italic>HERC2</italic> (HECT And RLD Domain Containing E3 Ubiquitin Protein Ligase 2, OMIM #605837), <italic>KCNH3</italic> (Potassium channel, voltage‐gated, subfamily H, member 3, OMIM #604527), and <italic>CACNA1A</italic> (calcium voltage‐gated channel subunit alpha1 A, OMIM #601011) were observed. Furthermore, Sanger sequencing was performed on DNA from the probands' parents to distinguish the transmission pattern or whether it is a de novo mutation. DNA from healthy siblings, brothers in both cases, also underwent sequencing to investigate whether they inherited these variations. This helped in shedding light on the potential clinical impact of these variations.</p>
<table-wrap id="mgg3992-tbl-0002" orientation="portrait" position="float" xml:lang="en">
<label>Table 2</label>
<caption>
<p>Mutations and polymorphisms resulting in amino acid changes in genes potentially implicated in agenesis of the corpus callosum in affected men</p>
</caption>
<table frame="hsides" rules="groups">
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<col span="1" style="border-right:solid 1px #000000"/>
<thead valign="top">
<tr style="border-bottom:solid 1px #000000">
<th align="left" colspan="1" rowspan="1" valign="top">Patient</th>
<th align="left" colspan="1" rowspan="1" valign="top">Gene</th>
<th align="left" colspan="1" rowspan="1" valign="top">SNP ID</th>
<th align="left" colspan="1" rowspan="1" valign="top">HGVS</th>
<th align="left" colspan="1" rowspan="1" valign="top">Frequency (ExAC)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Variation</th>
<th align="left" colspan="1" rowspan="1" valign="top">Consequence</th>
<th align="left" colspan="1" rowspan="1" valign="top">Impact (PolyPhen‐2, SIFT)</th>
<th align="left" colspan="1" rowspan="1" valign="top">Proband genotype</th>
<th align="left" colspan="1" rowspan="1" valign="top">Maternal genotype</th>
<th align="left" colspan="1" rowspan="1" valign="top">Paternal genotype</th>
<th align="left" colspan="1" rowspan="1" valign="top">Sibling genotype</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left" colspan="1" rowspan="4">1</td>
<td align="left" colspan="1" rowspan="1">
<italic>MCOLN1</italic>
</td>
<td align="left" colspan="1" rowspan="1">rs73003348</td>
<td align="left" colspan="1" rowspan="1">NC_000019.9:g.7593048C&gt;T</td>
<td align="left" colspan="1" rowspan="1">3.04E‐03</td>
<td align="left" colspan="1" rowspan="1">missense SNV</td>
<td align="left" colspan="1" rowspan="1">p.Thr261Met</td>
<td align="left" colspan="1" rowspan="1">Benign, tolerated</td>
<td align="left" colspan="1" rowspan="1">CT</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3">
<italic>HERC2</italic>
</td>
<td align="left" colspan="1" rowspan="1">rs765206957</td>
<td align="left" colspan="1" rowspan="1">NC_000015.9:g.28380739T&gt;C</td>
<td align="left" colspan="1" rowspan="1">4.94E‐05</td>
<td align="left" colspan="1" rowspan="1">missense SNV</td>
<td align="left" colspan="1" rowspan="1">p.Ile4039Val</td>
<td align="left" colspan="1" rowspan="1">Possibly damaging</td>
<td align="left" colspan="1" rowspan="1">CT</td>
<td align="left" colspan="1" rowspan="1">TT</td>
<td align="left" colspan="1" rowspan="1">CT</td>
<td align="left" colspan="1" rowspan="1">CT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs757141755</td>
<td align="left" colspan="1" rowspan="1">NC_000015.9:g.28391439C&gt;T</td>
<td align="left" colspan="1" rowspan="1">2.47E‐05</td>
<td align="left" colspan="1" rowspan="1">missense SNV</td>
<td align="left" colspan="1" rowspan="1">p.Arg3651His</td>
<td align="left" colspan="1" rowspan="1">Probably damaging</td>
<td align="left" colspan="1" rowspan="1">CT</td>
<td align="left" colspan="1" rowspan="1">TT</td>
<td align="left" colspan="1" rowspan="1">CC</td>
<td align="left" colspan="1" rowspan="1">CT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">rs138059246</td>
<td align="left" colspan="1" rowspan="1">NC_000015.9:g.28459392G&gt;A</td>
<td align="left" colspan="1" rowspan="1">8.57E‐04</td>
<td align="left" colspan="1" rowspan="1">missense SNV</td>
<td align="left" colspan="1" rowspan="1">p.Arg2129Cys</td>
<td align="left" colspan="1" rowspan="1">Probably damaging</td>
<td align="left" colspan="1" rowspan="1">AG</td>
<td align="left" colspan="1" rowspan="1">AA</td>
<td align="left" colspan="1" rowspan="1">GG</td>
<td align="left" colspan="1" rowspan="1">AG</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">2</td>
<td align="left" colspan="1" rowspan="2">
<italic>DCLK2</italic>
</td>
<td align="left" colspan="1" rowspan="1">rs200222469</td>
<td align="left" colspan="1" rowspan="1">
<p>NC_000004.11:g.151000277G&gt;A</p>
<p>NC_000004.11:g.151000277G&gt;T</p>
</td>
<td align="left" colspan="1" rowspan="1">1.89E‐04</td>
<td align="left" colspan="1" rowspan="1">missense SNV</td>
<td align="left" colspan="1" rowspan="1">p.Gly33Val</td>
<td align="left" colspan="1" rowspan="1">Benign, tolerated</td>
<td align="left" colspan="1" rowspan="1">GT</td>
<td align="left" colspan="1" rowspan="1">GT</td>
<td align="left" colspan="1" rowspan="1">GG</td>
<td align="left" colspan="1" rowspan="1">GT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NC_000004.11:g.151170745T&gt;A</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">missense SNV</td>
<td align="left" colspan="1" rowspan="1">p.Met661Lys</td>
<td align="left" colspan="1" rowspan="1">Probably damaging</td>
<td align="left" colspan="1" rowspan="1">AT</td>
<td align="left" colspan="1" rowspan="1">TT</td>
<td align="left" colspan="1" rowspan="1">AT</td>
<td align="left" colspan="1" rowspan="1">TT</td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="3">3</td>
<td align="left" colspan="1" rowspan="1">
<italic>CACNA1A</italic>
</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">non‐frameshift insertion</td>
<td align="left" colspan="1" rowspan="1">p.Pro2312_ Gln2313ins</td>
<td align="left" colspan="1" rowspan="1">unknown</td>
<td align="left" colspan="1" rowspan="1">possible homozygous</td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="2">
<italic>KCNH3</italic>
</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NC_000012.11:g.49936607G&gt;T</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">missense SNV</td>
<td align="left" colspan="1" rowspan="1">p.Lys188Asn</td>
<td align="left" colspan="1" rowspan="1">Possibly damaging</td>
<td align="left" colspan="1" rowspan="1">GT</td>
<td align="left" colspan="1" rowspan="1">GT</td>
<td align="left" colspan="1" rowspan="1">GG</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">NC_000012.11:g.49936608C&gt;T</td>
<td align="left" colspan="1" rowspan="1">NA</td>
<td align="left" colspan="1" rowspan="1">missense SNV</td>
<td align="left" colspan="1" rowspan="1">p.His189Tyr</td>
<td align="left" colspan="1" rowspan="1">Possibly damaging</td>
<td align="left" colspan="1" rowspan="1">CT</td>
<td align="left" colspan="1" rowspan="1">CT</td>
<td align="left" colspan="1" rowspan="1">CC</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
<tr>
<td align="left" colspan="1" rowspan="1">4</td>
<td align="left" colspan="1" rowspan="1">
<italic>MCOLN1</italic>
</td>
<td align="left" colspan="1" rowspan="1">rs148748724</td>
<td align="left" colspan="1" rowspan="1">NC_000019.9:g.7591493G&gt;A</td>
<td align="left" colspan="1" rowspan="1">2.48E‐05</td>
<td align="left" colspan="1" rowspan="1">splice donor</td>
<td align="left" colspan="1" rowspan="1">c.405+1G&gt;A</td>
<td align="left" colspan="1" rowspan="1">Pathogenic</td>
<td align="left" colspan="1" rowspan="1">AA (de novo mutation)</td>
<td align="left" colspan="1" rowspan="1">GG</td>
<td align="left" colspan="1" rowspan="1">AG</td>
<td align="left" colspan="1" rowspan="1"> </td>
</tr>
</tbody>
</table>
<table-wrap-foot id="mgg3992-ntgp-0001">
<fn id="mgg3992-note-0001">
<p>Abbreviations: <italic>CACNA1A</italic>, calcium voltage‐gated channel subunit alpha1 A; <italic>DCLK2</italic>, Doublecortin Like Kinase 2; ExAC, Exome Aggregation Consortium; <italic>HERC2</italic>, HECT And RLD Domain Containing E3 Ubiquitin Protein Ligase 2; HGVS, The Human Genome Variation Society Nomenclature; <italic>KCNH3</italic>, Potassium channel, voltage‐gated, subfamily H, member 3; <italic>MCOLN1</italic>, Mucolipin‐1; NA, data not available; PolyPhen‐2, Polymorphism Phenotyping v2; SIFT, Sorting Intolerant From Tolerant; SNP ID, single‐nucleotide polymorphism database identification; SNV, Single‐nucleotide variation.</p>
</fn>
</table-wrap-foot>
<permissions>
<copyright-holder>John Wiley &amp; Sons, Ltd</copyright-holder>
</permissions>
</table-wrap>
<p>Variations in <italic>HERC2</italic> (coding for HECT And RLD Domain Containing E3 Ubiquitin Protein Ligase 2), which is often associated with neurodevelopmental disorders, (Cubillos‐Rojas et al., <xref ref-type="ref" rid="mgg3992-bib-0005">2016</xref>; Puffenberger et al., <xref ref-type="ref" rid="mgg3992-bib-0019">2012</xref>; Tan, Bird, Thibert, &amp; Williams, <xref ref-type="ref" rid="mgg3992-bib-0022">2014</xref>) are relevant for one case (patient 1). This proband is heterozygous for three SNVs in this gene (rs765206957 (NC_000015.9:g.28380739T&gt;C), rs757141755 (NC_000015.9:g.28391439C&gt;T), rs138059246 (NC_000015.9:g.28459392G&gt;A)), which were inherited from either one of his parents (Table <xref ref-type="table" rid="mgg3992-tbl-0002">2</xref>). Thus, this proband has three multiple heterozygous variations in the <italic>HERC2</italic>, which may impact <italic>HERC2</italic> expression and protein production. Using PolyPhen‐2, the possible impact of amino acid substitution on protein function was predicted (Adzhubei et al., <xref ref-type="ref" rid="mgg3992-bib-0003">2010</xref>). The impact of nonsynonymous variations is based on sequence homology and physical properties of amino acids (Table <xref ref-type="table" rid="mgg3992-tbl-0002">2</xref>). According to PolyPhen‐2, two of these three SNVs are thought to be probably damaging the protein function. Nevertheless, his mother is homozygous for both these variations. The proband's brother (healthy) carries the same genetic profile for <italic>HERC2</italic>, as both siblings are heterozygous for these three variations (Figure <xref ref-type="fig" rid="mgg3992-fig-0001">1</xref>).</p>
<fig fig-type="Figure" id="mgg3992-fig-0001" orientation="portrait" position="float" xml:lang="en">
<label>Figure 1</label>
<caption>
<p>Genetic pedigrees of the four probands in this study. <italic>DCLK2</italic>, Doublecortin‐Like Kinase 2; <italic>HERC2</italic>, HECT And RLD Domain Containing E3 Ubiquitin Protein Ligase 2; <italic>KCNH3</italic>, Potassium channel, voltage‐gated, subfamily H, member 3; <italic>MCOLN1</italic>, Mucolipin‐1</p>
</caption>
<graphic id="nlm-graphic-3" xlink:href="MGG3-8-e992-g001"></graphic>
</fig>
<p>Our analyses also pointed out two variations in the <italic>DCLK2</italic> (coding for Doublecortin Like Kinase 2) in another proband (patient 2). A missense variation (rs200222469 (NC_000004.11:g.151000277G&gt;A, NC_000004.11:g.151000277G&gt;T)) was identified along with another nonsynonymous SNV in <italic>DCLK2</italic> in this patient. Very little information is known on this second SNV at position chr4:151170745 (p.Met661Lys). Interestingly, the proband is the only family member affected by both these variations (Table <xref ref-type="table" rid="mgg3992-tbl-0002">2</xref> and Figure <xref ref-type="fig" rid="mgg3992-fig-0001">1</xref>).</p>
<p>Furthermore, variations in two other genes were observed in our probands with the pathological phenotype. Patient 3 holds a non‐frameshift insertion in the <italic>CACNA1A</italic>, encoding for calcium voltage‐gated channel subunit alpha1 A. He also carries two variations in <italic>KCNH3</italic>, which encodes for the potassium channel, voltage‐gated, subfamily H, member 3. Nevertheless, this proband inherited these <italic>KCNH3</italic> variations from his mother. Unfortunately, we were unable to determine the transmission pattern for the variation in <italic>CACNA1A</italic> since adequate PCR amplification for this gene was impossible due to the nucleotide sequence specificities and difficulties in performing the technique.</p>
<p>Although, one patient (patient 4) did not have mutations in genes related to ACC, this study showed that he carried a de novo pathogenic mutation in Mucolipin‐1 (<italic>MCOLN1</italic>). A Mucolipidosis type IV diagnostic was made by a clinician and subsequent genetic counseling and screening was offered to the paternal family of this proband since one disease‐associated allele, based on ClinVar (rs148748724 (NC_000019.9:g.7591493G&gt;A)), was transmitted by his father (Table <xref ref-type="table" rid="mgg3992-tbl-0002">2</xref>). Another patient (patient 1) also carried a variation in <italic>MCOLN1</italic>, but this nonsynonymous variation is potentially benign according to PolyPhen‐2 (Polymorphism Phenotyping v2) prediction tool (Adzhubei et al., <xref ref-type="ref" rid="mgg3992-bib-0003">2010</xref>). Thus, sequencing was not performed for this region of the gene.</p>
</sec>
<sec id="mgg3992-sec-0013" sec-type="discussion">
<label>4</label>
<title>DISCUSSION</title>
<p>Clinical manifestations of ACC, a common abnormality in the brain structure, vary from asymptomatic to delayed development, hypotonia, epilepsy, and microcephaly. In the SLSJ region, several pediatricians noticed that patients with partial ACC without polyneuropathy had hypotonia and later presented epilepsy, developmental delay, microcephaly, midfacial hypoplasia, low hair implantation, and autistic behavior (Table <xref ref-type="table" rid="mgg3992-tbl-0001">1</xref>). WES was performed on four probands with the pathological phenotype and rare variants (&lt;1%) in genes involved in the development and/or the integrity of motoneurons were highlighted. Although we were not able to identify a novel susceptibility variant for ACC in this study, we provide evidence for new avenues of investigation, such as molecular pathways involving <italic>HERC2</italic>, <italic>CACNA1A</italic>, <italic>KCNH3,</italic> and more importantly <italic>DCLK2</italic>. Indeed, the four probands, although they exhibit similar clinical characteristics, do not share a common genetic disorder. It is also possible that a common mutation was not discovered using WES, since this technique only covers exons. These analyses allowed to identify that, in most cases, at least one parent is a heterozygous carrier for the variations found in their affected child (Figure <xref ref-type="fig" rid="mgg3992-fig-0001">1</xref>). Thus, further studies and functional assays are required to clearly understand whether these genes play a role in the development of ACC.</p>
<p>The implication of <italic>HERC2</italic> might not be surprising because of its implication in developmental delay, autism spectrum disorder, as well as Angelman‐like features (Puffenberger et al., <xref ref-type="ref" rid="mgg3992-bib-0019">2012</xref>; Tan et al., <xref ref-type="ref" rid="mgg3992-bib-0022">2014</xref>). Indeed, both studies identified a missense mutation in <italic>HERC2</italic> (rs397518474). Nevertheless, this mutation was not observed in patient 1 (Table <xref ref-type="table" rid="mgg3992-tbl-0002">2</xref>). In another study, mutations in <italic>HERC2</italic> were associated with three cases of absence of the posterior half of the corpus callosum (Harlalka et al., <xref ref-type="ref" rid="mgg3992-bib-0010">2013</xref>). In our study, although the proband's brother carries the same genotype for the <italic>HERC2</italic>, reduced penetrance and variable expressivity may affect the pattern of inheritance and may contribute to explain why only one sibling is affected by the disease. Further investigation is mandatory to demonstrate the pathogenic implication of the mutations found in this patient.</p>
<p>
<italic>KCNH3</italic> is mainly expressed in the brain and was previously associated with cognitive function (Miyake et al., <xref ref-type="ref" rid="mgg3992-bib-0016">2009</xref>). These alterations in cognitive function were also observed in <italic>KCNH3</italic> heterozygous mutant mice. Taken together, these alterations may impact the development and/or progression of ACC and associated disorders observed in this proband. Nevertheless, the affected child shares these mutations with his mother. Thus, taken alone, these mutations do not seem to induce ACC since the mother is not affected by this disease. More studies will be needed to demystify the underlying mechanisms involved in the types of interaction that regulate the genetics of this complex disease since the mutations potentially implicated in ACC development in patients 1 and 3 do not show regular segregation patterns, as concordance between genotypes and phenotypes is not always present.</p>
<p>Our results also pointed out the potential implication of the calcium channel CACNA1A. In the literature, a missense mutation in <italic>CACNA1A</italic> was observed in a patient affected by encephalopathy with a thin corpus callosum (Hayashida et al., <xref ref-type="ref" rid="mgg3992-bib-0011">2018</xref>). Although our proband was not affected by the same mutation, a non‐frameshift insertion may alter the calcium channel formation and impact the development of ACC. Moreover, alterations in another isoform of this calcium channel were associated with ACC in a study by Sajan et al. (<xref ref-type="ref" rid="mgg3992-bib-0020">2013</xref>). They reported that rare copy number variants in <italic>CACNA1B</italic> could be considered as genetic risk factors in ACC patients. Furthermore, Damaj et al. also demonstrated that some patients carrying <italic>CACNA1A</italic> mutations develop epilepsy, autism, and cognitive impairment (Damaj et al., <xref ref-type="ref" rid="mgg3992-bib-0006">2015</xref>). Thus, functional studies should be conducted to pinpoint the role of CACNA1A in the pathophysiology of ACC.</p>
<p>Regarding the implication of <italic>DCLK</italic> mutations, mice studies exhibited a role for DCLK in cortical neuronal migration and commissure formation. Deuel et al. showed that <italic>Dclk</italic> mutant mice exhibit axonal defects, which affected the corpus callosum (Deuel et al., <xref ref-type="ref" rid="mgg3992-bib-0008">2006</xref>). Patient 2 holds missense mutations in <italic>DCLK</italic>, which could impact the development and/or progression of ACC and related disorders in this affected patient. Interestingly, the rs200222469 variant was reported in a patient with ACC in Geno<sub>2</sub>MP, a database of rare variants from the University of Washington Center for Mendelian Genomics <xref ref-type="ref" rid="mgg3992-bib-0001">(UW‐CMG)</xref>. Furthermore, this proband is the only family member affected by both these mutations. Thus, this compound heterozygosity could have had a detrimental effect on the corpus callosum and unfortunately lead to ACC development by altering this serine/threonine‐protein kinase.</p>
<p>In conclusion, although the probands exhibited the same pathological phenotype, they do not seem to be affected by a common genetic disorder, but rather a combination of several diseases or syndromes presenting common clinical signs. Although our findings do not suggest a common ACC susceptibility gene, they provide new insights into molecular pathways involving <italic>HERC2</italic>, <italic>CACNA1A</italic>, <italic>KCNH3,</italic> and more interestingly <italic>DCLK2</italic> that could possibly be implicated in ACC development since they are all key players in motoneurons development and integrity.</p>
</sec>
<sec id="mgg3992-sec-0014" sec-type="COI-statement">
<title>CONFLICT OF INTEREST</title>
<p>None.</p>
</sec>
</body>
<back>
<ack id="mgg3992-sec-0015">
<title>ACKNOWLEDGMENTS</title>
<p>We thank the patients and their families for their valuable participation in this study. We also thank collaborators, especially the <italic>Plateforme de Séquençage et de Génotypage des Génomes</italic> of Quebec City, as well as the funding agencies. Jolyane Meloche received a Fonds de recherche du Québec ‒ Santé Postdoctoral training scholarship. This project was supported by the <italic>Fondation Louis‐Philippe Gagnon</italic> and operating grants from the Canadian Institute of Health Research (CIHR). Catherine Laprise is the co‐director of the Environment / Genetic / Cancer research axis of the Respiratory Health Network (RHN), investigator of CHILD Study and is a member of the AllerGen NCE Inc. and the chairholder of the Canada Research Chair in the Environment and Genetics of Respiratory Disorders and Allergies (<ext-link ext-link-type="uri" xlink:href="http://www.chairs.gc.ca">http://www.chairs.gc.ca</ext-link>).</p>
</ack>
<ref-list content-type="cited-references" id="mgg3992-bibl-0001">
<title>REFERENCES</title>
<ref id="mgg3992-bib-0001">
<mixed-citation id="mgg3992-cit-0001" publication-type="miscellaneous">
<collab collab-type="authors">(UW‐CMG)</collab>
, N. N. U. o. W.‐C. f. M. G. Geno2MP. <ext-link ext-link-type="uri" xlink:href="http://geno2mp.gs.washington.edu">http://geno2mp.gs.washington.edu</ext-link> 05/2018.</mixed-citation>
</ref>
<ref id="mgg3992-bib-0002">
<mixed-citation id="mgg3992-cit-0002" publication-type="journal">
<string-name>
<surname>Aboitiz</surname>, <given-names>F.</given-names>
</string-name>, &amp; <string-name>
<surname>Montiel</surname>, <given-names>J.</given-names>
</string-name> (<year>2003</year>). <article-title>One hundred million years of interhemispheric communication: The history of the corpus callosum</article-title>. <source xml:lang="en"/>Brazilian Journal of Medical and Biological Research, <volume>36</volume>(<issue>4</issue>), <fpage>409</fpage>–<lpage>420</lpage>. <pub-id pub-id-type="doi">10.1590/S0100-879X2003000400002</pub-id>
<pub-id pub-id-type="pmid">12700818</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0003">
<mixed-citation id="mgg3992-cit-0003" publication-type="journal">
<string-name>
<surname>Adzhubei</surname>, <given-names>I. A.</given-names>
</string-name>, <string-name>
<surname>Schmidt</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Peshkin</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Ramensky</surname>, <given-names>V. E.</given-names>
</string-name>, <string-name>
<surname>Gerasimova</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Bork</surname>, <given-names>P.</given-names>
</string-name>, … <string-name>
<surname>Sunyaev</surname>, <given-names>S. R.</given-names>
</string-name> (<year>2010</year>). <article-title>A method and server for predicting damaging missense mutations</article-title>. <source xml:lang="en"/>Nature Methods, <volume>7</volume>(<issue>4</issue>), <fpage>248</fpage>–<lpage>249</lpage>. <pub-id pub-id-type="doi">10.1038/nmeth0410-248</pub-id>
<pub-id pub-id-type="pmid">20354512</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0004">
<mixed-citation id="mgg3992-cit-0004" publication-type="journal">
<string-name>
<surname>Bedeschi</surname>, <given-names>M. F.</given-names>
</string-name>, <string-name>
<surname>Bonaglia</surname>, <given-names>M. C.</given-names>
</string-name>, <string-name>
<surname>Grasso</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Pellegri</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Garghentino</surname>, <given-names>R. R.</given-names>
</string-name>, <string-name>
<surname>Battaglia</surname>, <given-names>M. A.</given-names>
</string-name>, … <string-name>
<surname>Borgatti</surname>, <given-names>R.</given-names>
</string-name> (<year>2006</year>). <article-title>Agenesis of the corpus callosum: Clinical and genetic study in 63 young patients</article-title>. <source xml:lang="en"/>Pediatric Neurology, <volume>34</volume>(<issue>3</issue>), <fpage>186</fpage>–<lpage>193</lpage>. <pub-id pub-id-type="doi">10.1016/j.pediatrneurol.2005.08.008</pub-id>
<pub-id pub-id-type="pmid">16504787</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0005">
<mixed-citation id="mgg3992-cit-0005" publication-type="journal">
<string-name>
<surname>Cubillos‐Rojas</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Schneider</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Hadjebi</surname>, <given-names>O.</given-names>
</string-name>, <string-name>
<surname>Pedrazza</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>de Oliveira</surname>, <given-names>J. R.</given-names>
</string-name>, <string-name>
<surname>Langa</surname>, <given-names>F.</given-names>
</string-name>, … <string-name>
<surname>Rosa</surname>, <given-names>J. L.</given-names>
</string-name> (<year>2016</year>). <article-title>The HERC2 ubiquitin ligase is essential for embryonic development and regulates motor coordination</article-title>. <source xml:lang="en"/>Oncotarget, <volume>7</volume>(<issue>35</issue>), <fpage>56083</fpage>–<lpage>56106</lpage>. <pub-id pub-id-type="doi">10.18632/oncotarget.11270</pub-id>
<pub-id pub-id-type="pmid">27528230</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0006">
<mixed-citation id="mgg3992-cit-0006" publication-type="journal">
<string-name>
<surname>Damaj</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Lupien‐Meilleur</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Lortie</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Riou</surname>, <given-names>É.</given-names>
</string-name>, <string-name>
<surname>Ospina</surname>, <given-names>L. H.</given-names>
</string-name>, <string-name>
<surname>Gagnon</surname>, <given-names>L.</given-names>
</string-name>, … <string-name>
<surname>Rossignol</surname>, <given-names>E.</given-names>
</string-name> (<year>2015</year>). <article-title>CACNA1A haploinsufficiency causes cognitive impairment, autism and epileptic encephalopathy with mild cerebellar symptoms</article-title>. <source xml:lang="en"/>European Journal of Human Genetics, <volume>23</volume>(<issue>11</issue>), <fpage>1505</fpage>–<lpage>1512</lpage>. <pub-id pub-id-type="doi">10.1038/ejhg.2015.21</pub-id>
<pub-id pub-id-type="pmid">25735478</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0007">
<mixed-citation id="mgg3992-cit-0007" publication-type="journal">
<string-name>
<surname>De Braekeleer</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Dallaire</surname>, <given-names>A.</given-names>
</string-name>, &amp; <string-name>
<surname>Mathieu</surname>, <given-names>J.</given-names>
</string-name> (<year>1993</year>). <article-title>Genetic epidemiology of sensorimotor polyneuropathy with or without agenesis of the corpus callosum in northeastern Quebec</article-title>. <source xml:lang="en"/>Human Genetics, <volume>91</volume>(<issue>3</issue>), <fpage>223</fpage>–<lpage>227</lpage>. <pub-id pub-id-type="doi">10.1007/BF00218260</pub-id>
<pub-id pub-id-type="pmid">8386695</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0008">
<mixed-citation id="mgg3992-cit-0008" publication-type="journal">
<string-name>
<surname>Deuel</surname>, <given-names>T. A.</given-names>
</string-name>, <string-name>
<surname>Liu</surname>, <given-names>J. S.</given-names>
</string-name>, <string-name>
<surname>Corbo</surname>, <given-names>J. C.</given-names>
</string-name>, <string-name>
<surname>Yoo</surname>, <given-names>S. Y.</given-names>
</string-name>, <string-name>
<surname>Rorke‐Adams</surname>, <given-names>L. B.</given-names>
</string-name>, &amp; <string-name>
<surname>Walsh</surname>, <given-names>C. A.</given-names>
</string-name> (<year>2006</year>). <article-title>Genetic interactions between doublecortin and doublecortin‐like kinase in neuronal migration and axon outgrowth</article-title>. <source xml:lang="en"/>Neuron, <volume>49</volume>(<issue>1</issue>), <fpage>41</fpage>–<lpage>53</lpage>. <pub-id pub-id-type="doi">10.1016/j.neuron.2005.10.038</pub-id>
<pub-id pub-id-type="pmid">16387638</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0009">
<mixed-citation id="mgg3992-cit-0009" publication-type="journal">
<string-name>
<surname>Dupré</surname>, <given-names>N.</given-names>
</string-name>, <string-name>
<surname>Howard</surname>, <given-names>H. C.</given-names>
</string-name>, <string-name>
<surname>Mathieu</surname>, <given-names>J.</given-names>
</string-name>, <string-name>
<surname>Karpati</surname>, <given-names>G.</given-names>
</string-name>, <string-name>
<surname>Vanasse</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Bouchard</surname>, <given-names>J.‐P.</given-names>
</string-name>, … <string-name>
<surname>Rouleau</surname>, <given-names>G. A.</given-names>
</string-name> (<year>2003</year>). <article-title>Hereditary motor and sensory neuropathy with agenesis of the corpus callosum</article-title>. <source xml:lang="en"/>Annals of Neurology, <volume>54</volume>(<issue>1</issue>), <fpage>9</fpage>–<lpage>18</lpage>. <pub-id pub-id-type="doi">10.1002/ana.77777</pub-id>
<pub-id pub-id-type="pmid">12838516</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0010">
<mixed-citation id="mgg3992-cit-0010" publication-type="journal">
<string-name>
<surname>Harlalka</surname>, <given-names>G. V.</given-names>
</string-name>, <string-name>
<surname>Baple</surname>, <given-names>E. L.</given-names>
</string-name>, <string-name>
<surname>Cross</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Kühnle</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Cubillos‐Rojas</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Matentzoglu</surname>, <given-names>K.</given-names>
</string-name>, … <string-name>
<surname>Crosby</surname>, <given-names>A. H.</given-names>
</string-name> (<year>2013</year>). <article-title>Mutation of HERC2 causes developmental delay with Angelman‐like features</article-title>. <source xml:lang="en"/>Journal of Medical Genetics, <volume>50</volume>(<issue>2</issue>), <fpage>65</fpage>–<lpage>73</lpage>. <pub-id pub-id-type="doi">10.1136/jmedgenet-2012-101367</pub-id>
<pub-id pub-id-type="pmid">23243086</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0011">
<mixed-citation id="mgg3992-cit-0011" publication-type="journal">
<string-name>
<surname>Hayashida</surname>, <given-names>T.</given-names>
</string-name>, <string-name>
<surname>Saito</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Ishii</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Yamada</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Itakura</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Minato</surname>, <given-names>T.</given-names>
</string-name>, … <string-name>
<surname>Hirose</surname>, <given-names>S.</given-names>
</string-name> (<year>2018</year>). <article-title>CACNA1A‐related early‐onset encephalopathy with myoclonic epilepsy: A case report</article-title>. <source xml:lang="en"/>Brain and Development, <volume>40</volume>(<issue>2</issue>), <fpage>130</fpage>–<lpage>133</lpage>. <pub-id pub-id-type="doi">10.1016/j.braindev.2017.08.006</pub-id>
<pub-id pub-id-type="pmid">28927557</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0012">
<mixed-citation id="mgg3992-cit-0012" publication-type="journal">
<string-name>
<surname>Larbrisseau</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Vanasse</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Brochu</surname>, <given-names>P.</given-names>
</string-name>, &amp; <string-name>
<surname>Jasmin</surname>, <given-names>G.</given-names>
</string-name> (<year>1984</year>). <article-title>The Andermann syndrome: Agenesis of the corpus callosum associated with mental retardation and progressive sensorimotor neuronopathy</article-title>. <source xml:lang="en"/>Canadian Journal of Neurological Sciences, <volume>11</volume>(<issue>2</issue>), <fpage>257</fpage>–<lpage>261</lpage>. <pub-id pub-id-type="doi">10.1017/S0317167100045509</pub-id>
<pub-id pub-id-type="pmid">6329500</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0013">
<mixed-citation id="mgg3992-cit-0013" publication-type="journal">
<string-name>
<surname>Lek</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Karczewski</surname>, <given-names>K. J.</given-names>
</string-name>, <string-name>
<surname>Minikel</surname>, <given-names>E. V.</given-names>
</string-name>, <string-name>
<surname>Samocha</surname>, <given-names>K. E.</given-names>
</string-name>, <string-name>
<surname>Banks</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Fennell</surname>, <given-names>T.</given-names>
</string-name>, … <string-name>
<surname>MacArthur</surname>, <given-names>D. G.</given-names>
</string-name> (<year>2016</year>). <article-title>Analysis of protein‐coding genetic variation in 60,706 humans</article-title>. <source xml:lang="en"/>Nature, <volume>536</volume>(<issue>7616</issue>), <fpage>285</fpage>–<lpage>291</lpage>. <pub-id pub-id-type="doi">10.1038/nature19057</pub-id>
<pub-id pub-id-type="pmid">27535533</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0014">
<mixed-citation id="mgg3992-cit-0014" publication-type="journal">
<string-name>
<surname>Li</surname>, <given-names>H.</given-names>
</string-name>, &amp; <string-name>
<surname>Durbin</surname>, <given-names>R.</given-names>
</string-name> (<year>2009</year>). <article-title>Fast and accurate short read alignment with Burrows‐Wheeler transform</article-title>. <source xml:lang="en"/>Bioinformatics, <volume>25</volume>(<issue>14</issue>), <fpage>1754</fpage>–<lpage>1760</lpage>. <pub-id pub-id-type="doi">10.1093/bioinformatics/btp324</pub-id>
<pub-id pub-id-type="pmid">19451168</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0015">
<mixed-citation id="mgg3992-cit-0015" publication-type="journal">
<string-name>
<surname>Mihrshahi</surname>, <given-names>R.</given-names>
</string-name> (<year>2006</year>). <article-title>The corpus callosum as an evolutionary innovation</article-title>. <source xml:lang="en"/>Journal of Experimental Zoology Part B: Molecular and Developmental Evolution, <volume>306</volume>(<issue>1</issue>), <fpage>8</fpage>–<lpage>17</lpage>. <pub-id pub-id-type="doi">10.1002/jez.b.21067</pub-id>
</mixed-citation>
</ref>
<ref id="mgg3992-bib-0016">
<mixed-citation id="mgg3992-cit-0016" publication-type="journal">
<string-name>
<surname>Miyake</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Takahashi</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Nakamura</surname>, <given-names>Y.</given-names>
</string-name>, <string-name>
<surname>Inamura</surname>, <given-names>K.</given-names>
</string-name>, <string-name>
<surname>Matsumoto</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Mochizuki</surname>, <given-names>S.</given-names>
</string-name>, &amp; <string-name>
<surname>Katou</surname>, <given-names>M.</given-names>
</string-name> (<year>2009</year>). <article-title>Disruption of the ether‐a‐go‐go K+ channel gene BEC1/KCNH3 enhances cognitive function</article-title>. <source xml:lang="en"/>Journal of Neuroscience, <volume>29</volume>(<issue>46</issue>), <fpage>14637</fpage>–<lpage>14645</lpage>. <pub-id pub-id-type="doi">10.1523/JNEUROSCI.0901-09.2009</pub-id>
<pub-id pub-id-type="pmid">19923296</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0017">
<mixed-citation id="mgg3992-cit-0017" publication-type="journal">
<string-name>
<surname>Ng</surname>, <given-names>P. C.</given-names>
</string-name>, &amp; <string-name>
<surname>Henikoff</surname>, <given-names>S.</given-names>
</string-name> (<year>2001</year>). <article-title>Predicting deleterious amino acid substitutions</article-title>. <source xml:lang="en"/>Genome Research, <volume>11</volume>(<issue>5</issue>), <fpage>863</fpage>–<lpage>874</lpage>. <pub-id pub-id-type="doi">10.1101/gr.176601</pub-id>
<pub-id pub-id-type="pmid">11337480</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0018">
<mixed-citation id="mgg3992-cit-0018" publication-type="journal">
<string-name>
<surname>Paul</surname>, <given-names>L. K.</given-names>
</string-name>, <string-name>
<surname>Brown</surname>, <given-names>W. S.</given-names>
</string-name>, <string-name>
<surname>Adolphs</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Tyszka</surname>, <given-names>J. M.</given-names>
</string-name>, <string-name>
<surname>Richards</surname>, <given-names>L. J.</given-names>
</string-name>, <string-name>
<surname>Mukherjee</surname>, <given-names>P.</given-names>
</string-name>, &amp; <string-name>
<surname>Sherr</surname>, <given-names>E. H.</given-names>
</string-name> (<year>2007</year>). <article-title>Agenesis of the corpus callosum: Genetic, developmental and functional aspects of connectivity</article-title>. <source xml:lang="en"/>Nature Reviews Neuroscience, <volume>8</volume>(<issue>4</issue>), <fpage>287</fpage>–<lpage>299</lpage>. <pub-id pub-id-type="doi">10.1038/nrn2107</pub-id>
<pub-id pub-id-type="pmid">17375041</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0019">
<mixed-citation id="mgg3992-cit-0019" publication-type="journal">
<string-name>
<surname>Puffenberger</surname>, <given-names>E. G.</given-names>
</string-name>, <string-name>
<surname>Jinks</surname>, <given-names>R. N.</given-names>
</string-name>, <string-name>
<surname>Wang</surname>, <given-names>H.</given-names>
</string-name>, <string-name>
<surname>Xin</surname>, <given-names>B.</given-names>
</string-name>, <string-name>
<surname>Fiorentini</surname>, <given-names>C.</given-names>
</string-name>, <string-name>
<surname>Sherman</surname>, <given-names>E. A.</given-names>
</string-name>, … <string-name>
<surname>Strauss</surname>, <given-names>K. A.</given-names>
</string-name> (<year>2012</year>). <article-title>A homozygous missense mutation in HERC2 associated with global developmental delay and autism spectrum disorder</article-title>. <source xml:lang="en"/>Human Mutation, <volume>33</volume>(<issue>12</issue>), <fpage>1639</fpage>–<lpage>1646</lpage>. <pub-id pub-id-type="doi">10.1002/humu.22237</pub-id>
<pub-id pub-id-type="pmid">23065719</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0020">
<mixed-citation id="mgg3992-cit-0020" publication-type="journal">
<string-name>
<surname>Sajan</surname>, <given-names>S. A.</given-names>
</string-name>, <string-name>
<surname>Fernandez</surname>, <given-names>L.</given-names>
</string-name>, <string-name>
<surname>Nieh</surname>, <given-names>S. E.</given-names>
</string-name>, <string-name>
<surname>Rider</surname>, <given-names>E.</given-names>
</string-name>, <string-name>
<surname>Bukshpun</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Wakahiro</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Sherr</surname>, <given-names>E. H.</given-names>
</string-name> (<year>2013</year>). <article-title>Both rare and de novo copy number variants are prevalent in agenesis of the corpus callosum but not in cerebellar hypoplasia or polymicrogyria</article-title>. <source xml:lang="en"/>PLoS Genetics, <volume>9</volume>(<issue>10</issue>), <elocation-id>e1003823</elocation-id>
<pub-id pub-id-type="doi">10.1371/journal.pgen.1003823</pub-id>
<pub-id pub-id-type="pmid">24098143</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0021">
<mixed-citation id="mgg3992-cit-0021" publication-type="journal">
<string-name>
<surname>Scriver</surname>, <given-names>C. R.</given-names>
</string-name> (<year>2001</year>). <article-title>Human genetics: Lessons from Quebec populations</article-title>. <source xml:lang="en"/>Annual Review of Genomics and Human Genetics, <volume>2</volume>, <fpage>69</fpage>–<lpage>101</lpage>. <pub-id pub-id-type="doi">10.1146/annurev.genom.2.1.69</pub-id>
</mixed-citation>
</ref>
<ref id="mgg3992-bib-0022">
<mixed-citation id="mgg3992-cit-0022" publication-type="journal">
<string-name>
<surname>Tan</surname>, <given-names>W. H.</given-names>
</string-name>, <string-name>
<surname>Bird</surname>, <given-names>L. M.</given-names>
</string-name>, <string-name>
<surname>Thibert</surname>, <given-names>R. L.</given-names>
</string-name>, &amp; <string-name>
<surname>Williams</surname>, <given-names>C. A.</given-names>
</string-name> (<year>2014</year>). <article-title>If not Angelman, what is it? A review of Angelman‐like syndromes</article-title>. <source xml:lang="en"/>American Journal of Medical Genetics. Part A, <volume>164A</volume>(<issue>4</issue>), <fpage>975</fpage>–<lpage>992</lpage>. <pub-id pub-id-type="doi">10.1002/ajmg.a.36416</pub-id>
<pub-id pub-id-type="pmid">24779060</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0023">
<mixed-citation id="mgg3992-cit-0023" publication-type="journal">
<string-name>
<surname>Taylor</surname>, <given-names>M.</given-names>
</string-name>, &amp; <string-name>
<surname>David</surname>, <given-names>A. S.</given-names>
</string-name> (<year>1998</year>). <article-title>Agenesis of the corpus callosum: A United Kingdom series of 56 cases</article-title>. <source xml:lang="en"/>Journal of Neurology, Neurosurgery and Psychiatry, <volume>64</volume>(<issue>1</issue>), <fpage>131</fpage>–<lpage>134</lpage>. <pub-id pub-id-type="doi">10.1136/jnnp.64.1.131</pub-id>
</mixed-citation>
</ref>
<ref id="mgg3992-bib-0024">
<mixed-citation id="mgg3992-cit-0024" publication-type="journal">
<string-name>
<surname>Topper</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Ober</surname>, <given-names>C.</given-names>
</string-name>, &amp; <string-name>
<surname>Das</surname>, <given-names>S.</given-names>
</string-name> (<year>2011</year>). <article-title>Exome sequencing and the genetics of intellectual disability</article-title>. <source xml:lang="en"/>Clinical Genetics, <volume>80</volume>(<issue>2</issue>), <fpage>117</fpage>–<lpage>126</lpage>. <pub-id pub-id-type="doi">10.1111/j.1399-0004.2011.01720.x</pub-id>
<pub-id pub-id-type="pmid">21627642</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0025">
<mixed-citation id="mgg3992-cit-0025" publication-type="journal">
<string-name>
<surname>van Bon</surname>, <given-names>B. W. M.</given-names>
</string-name>, <string-name>
<surname>Koolen</surname>, <given-names>D. A.</given-names>
</string-name>, <string-name>
<surname>Borgatti</surname>, <given-names>R.</given-names>
</string-name>, <string-name>
<surname>Magee</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Garcia‐Minaur</surname>, <given-names>S.</given-names>
</string-name>, <string-name>
<surname>Rooms</surname>, <given-names>L.</given-names>
</string-name>, … <string-name>
<surname>de Vries</surname>, <given-names>B. B. A.</given-names>
</string-name> (<year>2008</year>). <article-title>Clinical and molecular characteristics of 1qter microdeletion syndrome: Delineating a critical region for corpus callosum agenesis/hypogenesis</article-title>. <source xml:lang="en"/>Journal of Medical Genetics, <volume>45</volume>(<issue>6</issue>), <fpage>346</fpage>–<lpage>354</lpage>. <pub-id pub-id-type="doi">10.1136/jmg.2007.055830</pub-id>
<pub-id pub-id-type="pmid">18178631</pub-id></mixed-citation>
</ref>
<ref id="mgg3992-bib-0026">
<mixed-citation id="mgg3992-cit-0026" publication-type="journal">
<string-name>
<surname>Volpe</surname>, <given-names>P.</given-names>
</string-name>, <string-name>
<surname>Paladini</surname>, <given-names>D.</given-names>
</string-name>, <string-name>
<surname>Resta</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Stanziano</surname>, <given-names>A.</given-names>
</string-name>, <string-name>
<surname>Salvatore</surname>, <given-names>M.</given-names>
</string-name>, <string-name>
<surname>Quarantelli</surname>, <given-names>M.</given-names>
</string-name>, … <string-name>
<surname>Gentile</surname>, <given-names>M.</given-names>
</string-name> (<year>2006</year>). <article-title>Characteristics, associations and outcome of partial agenesis of the corpus callosum in the fetus</article-title>. <source xml:lang="en"/>Ultrasound in Obstetrics and Gynecology, <volume>27</volume>(<issue>5</issue>), <fpage>509</fpage>–<lpage>516</lpage>. <pub-id pub-id-type="doi">10.1002/uog.2774</pub-id>
<pub-id pub-id-type="pmid">16619387</pub-id></mixed-citation>
</ref>
</ref-list>
</back>
</article>
</pmc-articleset>